GW&K Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.85M | Sell |
3,509
-24,886
| -88% | -$14M | 0.01% | 322 |
|
|
2026
Q1 | $16M | Sell |
28,395
-715
| -2% | -$458K | 0.14% | 227 |
|
|
2025
Q4 | $19.7M | Buy |
29,110
+1
| +0% | +$681 | 0.17% | 207 |
|
|
2025
Q3 | $18.6M | Sell |
29,109
-5,572
| -16% | -$3.38M | 0.16% | 203 |
|
|
2025
Q2 | $18.6M | Sell |
34,681
-815
| -2% | -$390K | 0.17% | 208 |
|
|
2025
Q1 | $14.9M | Buy |
35,496
+1,049
| +3% | +$455K | 0.14% | 231 |
|
|
2024
Q4 | $14.2M | Sell |
34,447
-881
| -2% | -$386K | 0.12% | 246 |
|
|
2024
Q3 | $17.8M | Buy |
35,328
+9,948
| +39% | +$4.83M | 0.15% | 212 |
|
|
2024
Q2 | $12.4M | Sell |
25,380
-301
| -1% | -$151K | 0.11% | 239 |
|
|
2024
Q1 | $13.9M | Buy |
25,681
+217
| +0.9% | +$119K | 0.12% | 227 |
|
|
2023
Q4 | $14.1M | Sell |
25,464
-1,487
| -6% | -$698K | 0.13% | 213 |
|
|
2023
Q3 | $11.8M | Sell |
26,951
-630
| -2% | -$314K | 0.12% | 222 |
|
|
2023
Q2 | $13.9M | Sell |
27,581
-584
| -2% | -$280K | 0.13% | 207 |
|
|
2023
Q1 | $14.1M | Sell |
28,165
-6,502
| -19% | -$3.11M | 0.14% | 201 |
|
|
2022
Q4 | $14.1M | Sell |
34,667
-1,832
| -5% | -$711K | 0.14% | 193 |
|
|
2022
Q3 | $11.9M | Sell |
36,499
-1,192
| -3% | -$438K | 0.13% | 197 |
|
|
2022
Q2 | $13.2M | Sell |
37,691
-2,372
| -6% | -$967K | 0.14% | 196 |
|
|
2022
Q1 | $21.9M | Sell |
40,063
-1,099
| -3% | -$578K | 0.2% | 182 |
|
|
2021
Q4 | $27.1M | Sell |
41,162
-910
| -2% | -$571K | 0.23% | 169 |
|
|
2021
Q3 | $26.2M | Sell |
42,072
-6,517
| -13% | -$4.38M | 0.23% | 170 |
|
|
2021
Q2 | $30.7M | Buy |
48,589
+4,964
| +11% | +$2.74M | 0.27% | 163 |
|
|
2021
Q1 | $21.3M | Sell |
43,625
-1,010
| -2% | -$506K | 0.2% | 187 |
|
|
2020
Q4 | $22.3M | Sell |
44,635
-16,248
| -27% | -$7.27M | 0.23% | 182 |
|
|
2020
Q3 | $23.9M | Sell |
60,883
-626
| -1% | -$231K | 0.31% | 140 |
|
|
2020
Q2 | $20.3M | Buy |
61,509
+4,480
| +8% | +$1.3M | 0.29% | 157 |
|
|
2020
Q1 | $13.8M | Buy |
57,029
+56,761
| +21,179% | +$14.8M | 0.24% | 159 |
|
|
2019
Q4 | $70K | Hold |
268
| – | – | ﹤0.01% | 344 |
|
|
2019
Q3 | $73K | Buy |
+268
| New | +$74.6K | ﹤0.01% | 338 |
|
|
2018
Q2 | – | Sell |
-107,303
| Closed | -$20.5M | – | 293 |
|
|
2018
Q1 | $20.5M | Buy |
107,303
+7,727
| +8% | +$1.43M | 0.35% | 129 |
|
|
2017
Q4 | $15.6M | Buy |
99,576
+162
| +0.2% | +$25.5K | 0.27% | 152 |
|
|
2017
Q3 | $15.5M | Buy |
99,414
+648
| +0.7% | +$102K | 0.26% | 155 |
|
|
2017
Q2 | $15.9M | Sell |
98,766
-3,112
| -3% | -$505K | 0.28% | 147 |
|
|
2017
Q1 | $15.8M | Sell |
101,878
-3,572
| -3% | -$492K | 0.3% | 128 |
|
|
2016
Q4 | $12.4M | Sell |
105,450
-28,769
| -21% | -$3.28M | 0.24% | 151 |
|
|
2016
Q3 | $15.1M | Buy |
134,219
+27,068
| +25% | +$2.85M | 0.28% | 140 |
|
|
2016
Q2 | $9.95M | Sell |
107,151
-4,099
| -4% | -$352K | 0.21% | 152 |
|
|
2016
Q1 | $8.71M | Buy |
111,250
+12,837
| +13% | +$924K | 0.19% | 155 |
|
|
2015
Q4 | $7.18M | Buy |
98,413
+38,360
| +64% | +$2.74M | 0.17% | 155 |
|
|
2015
Q3 | $4.46M | Buy |
+60,053
| New | +$4.3M | 0.11% | 171 |
|
Other funds holding IDXX
GW&K Investment Management's IDXX Position: Q2 2026 in Review
GW&K Investment Management reduced its Idexx Laboratories (IDXX) stake by 88% in Q2 2026, selling an estimated $14M and leaving 3,509 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #322.
GW&K Investment Management first reported a position in IDXX in Q3 2015 and has held it in 39 quarters since. The position peaked at $30.7M in Q2 2021. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- GW&K Investment Management held 3,509 shares of Idexx Laboratories worth $1.85M as of Q2 2026.
- GW&K Investment Management sold 24,886 Idexx Laboratories shares in Q2 2026, an estimated $14M.
- Idexx Laboratories made up 0.01% of GW&K Investment Management's portfolio in Q2 2026, its #322 holding.
- GW&K Investment Management first reported a position in Idexx Laboratories in Q3 2015 and has held it in 39 quarters since.
- GW&K Investment Management's Idexx Laboratories position peaked at $30.7M in Q2 2021.
- 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.